Biological API Drug Manufacturing Market Size, Share and Forecast 2026
The Biological API drug manufacturing market was worth XX billion in 2018 and is forecasted to reach XX billion by 2026, at a CAGR of XX% during the forecast period.
(EMAILWIRE.COM, September 12, 2019 ) Market Overview:
The biological API involved in the fermentation of microorganisms and cultured in a substrate to produce a substance which is used in for treating disease eg: antibiotics, steroids and vaccines and other biological molecules used for the production of vaccines and genetically modified vaccines.
The Biological API drug manufacturing market was worth XX billion in 2018 and is forecasted to reach XX billion by 2026, at a CAGR of XX% during the forecast period.
Market Dynamics:
The surge in demand for biotechnology products and ongoing research by biopharmaceutical companies on therapeutic diseases majorly cancer, followed by autoimmune and cardiovascular diseases are driving the Biological API drug manufacturing.
Market Segmentation:
By Manufacturing Type
• In-House manufacturing
• API Contract Manufacturing
By Expression Platforms
• Mammalian cell culture
• Microbial fermentation
• Other expression platforms
By Application
• Monoclonal antibody (mAb) therapies
• Vaccines
• Insulin therapies
• Interferon therapies
• Growth hormones
Geographical Analysis:
The Biological API drug manufacturing market is segmented into:
• North America
• Europe
• Asia Pacific
• South America
• The Middle East & Africa
Competitive Analysis:
Key Players:
• Lonza
• Boehringer Ingelheim BioXcellence
• Celltrion
• DSM Biologics
• Samsung BioLogics
• Others
View full report: https://www.datamintelligence.com/research-report/biological-api-drug-manufacturing-market
Download free sample: https://www.datamintelligence.com/download-sample/biological-api-drug-manufacturing-market
About Us:
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
For more information:
Sai Kiran
Sales Manager at Data M Intelligence
Email: info@datamintelligence.com
Tel: +1 877 441 4866
Website: www.datamintelligence.com
The biological API involved in the fermentation of microorganisms and cultured in a substrate to produce a substance which is used in for treating disease eg: antibiotics, steroids and vaccines and other biological molecules used for the production of vaccines and genetically modified vaccines.
The Biological API drug manufacturing market was worth XX billion in 2018 and is forecasted to reach XX billion by 2026, at a CAGR of XX% during the forecast period.
Market Dynamics:
The surge in demand for biotechnology products and ongoing research by biopharmaceutical companies on therapeutic diseases majorly cancer, followed by autoimmune and cardiovascular diseases are driving the Biological API drug manufacturing.
Market Segmentation:
By Manufacturing Type
• In-House manufacturing
• API Contract Manufacturing
By Expression Platforms
• Mammalian cell culture
• Microbial fermentation
• Other expression platforms
By Application
• Monoclonal antibody (mAb) therapies
• Vaccines
• Insulin therapies
• Interferon therapies
• Growth hormones
Geographical Analysis:
The Biological API drug manufacturing market is segmented into:
• North America
• Europe
• Asia Pacific
• South America
• The Middle East & Africa
Competitive Analysis:
Key Players:
• Lonza
• Boehringer Ingelheim BioXcellence
• Celltrion
• DSM Biologics
• Samsung BioLogics
• Others
View full report: https://www.datamintelligence.com/research-report/biological-api-drug-manufacturing-market
Download free sample: https://www.datamintelligence.com/download-sample/biological-api-drug-manufacturing-market
About Us:
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
For more information:
Sai Kiran
Sales Manager at Data M Intelligence
Email: info@datamintelligence.com
Tel: +1 877 441 4866
Website: www.datamintelligence.com
Contact Information:
DataM Intelligence
Sai Kiran
Tel: +1 877 441 4866
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
DataM Intelligence
Sai Kiran
Tel: +1 877 441 4866
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results